BioMarin Pharmaceutical Inc (BMRN): Depreciation & Amortization
$79.56M
Year ended 2025-12-31
$152.97M
Trailing 12 months to 2026-06-30
-7.9%
3-year compound annual growth
-5.4%
5-year compound annual growth
+5.4%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $79.56M | -17.5% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $96.43M | -7.6% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $104.39M | +2.4% | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | $101.97M | -5.6% | 2025-02-24, From 2022-01-01 |
| 2021-12-31 | $108.04M | +2.7% | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | $105.17M | -0.1% | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | $105.30M | +10.1% | 2022-02-25, From 2019-01-01 |
| 2018-12-31 | $95.67M | +8.9% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $87.86M | -9.3% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $96.91M | +105.4% | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | $47.19M | +2.9% | 2018-02-26, From 2015-01-01 |
| 2014-12-31 | $45.87M | +27.4% | 2017-02-27, From 2014-01-01 |
| 2013-12-31 | $36.01M | n/a | 2016-02-29, From 2013-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $79.56M | -17.5% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $85.60M | +18.1% |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $55.66M | -1.8% |
| Perrigo Co PLC (PRGO) | 2025-12-31 | $337.50M | +3.6% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | $41.60M | +26.8% |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | $680.00M | +2.7% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $44.52M | +18.0% |
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $141.69M | -17.5% |
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $38.81M | -48.7% |
Compare BMRN, UTHR, ALNY, PRGO side by side · Screen every company in Pharmaceutical Preparations ↗